Stoke Therapeutics Inc. (STOK) Social Stream



Stoke Therapeutics Inc. (STOK): $25.11

-2.53 (-9.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add STOK to Watchlist
Sign Up

Industry: Biotech


Ranked

of 476

in industry

Stoke Therapeutics Inc (STOK) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering STOK.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
6 $76 $35 $57.571 $28.06 105.17%
6 $76 $35 $57.857 $28.06 106.19%
7 $76 $35 $57.857 $28.06 106.19%

The Trend in the Analyst Price Target


Over the past 31 weeks, STOK's average price target has gone down $11.14.

STOK reports an average of 69.75% for its upside potential over the past 18 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-12 6 76 35 57.571 28.42 102.57%
2020-05-15 7 46 30 37.400 NA NA%

STOK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 4 0 2 0 0 6

The Trend in the Broker Recommendations


STOK's average broker recommendation rating improved by 0.33 over the prior 26 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for STOK as an investment opportunity.

  • STOK has a less variance in analysts' estimates than -159.88% of all US stocks.
  • Stoke Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 248.77% of all US stocks.
  • The average analyst price target of STOK is higher than 244.4% of Pharmaceutical Products stocks.
  • STOK has a higher number of analysts covering the stock than 198.82% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Stoke Therapeutics Inc are YMAB, ABUS and VERV.

Is STOK a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5862 seconds.